Fig. 7From: Posttranslational modifications of proteins are key features in the identification of CSF biomarkers of multiple sclerosisTotal abundance of Rbp4 in the CSF (A) and serum (B) of patients diagnosed with Relapse–remitting multiple sclerosis (RRMS), non-inflammatory diseases of the CNS (N-INF), and with other inflammatory diseases of the CNS (INF), and further sub-divided by gender. The results represent the mean ± SEM and statistical analysis was performed by one-way ANOVA followed by the Tukey’s multiple comparison test, comparing all the indicated conditions (ns, p > 0.05; *p ˂ 0.05, **p ˂ 0.01)Back to article page